OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group
Marco Caminati, Angelo Fassio, Federico Alberici, et al.
Allergy (2023) Vol. 79, Iss. 2, pp. 516-519
Open Access | Times Cited: 12
Marco Caminati, Angelo Fassio, Federico Alberici, et al.
Allergy (2023) Vol. 79, Iss. 2, pp. 516-519
Open Access | Times Cited: 12
Showing 12 citing articles:
Safety of dupilumab in T2 airways conditions: focus on eosinophilia across trials and real-life evidence
Marco Caminati, Claudio Micheletto, Francesca Norelli, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 1-2, pp. 15-23
Closed Access | Times Cited: 7
Marco Caminati, Claudio Micheletto, Francesca Norelli, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 1-2, pp. 15-23
Closed Access | Times Cited: 7
Heterogeneity and individualized therapy for eosinophilic granulomatosis with polyangiitis
Lijuan Hua, Min Xie
Therapeutic Advances in Respiratory Disease (2025) Vol. 19
Open Access
Lijuan Hua, Min Xie
Therapeutic Advances in Respiratory Disease (2025) Vol. 19
Open Access
Highlights from the plenary session: eosinophilic granulomatosis with polyangiitis and hypereosinophilic syndrome
Julia U. Holle, Augusto Vaglio
Lara D. Veeken (2025) Vol. 64, Iss. Supplement_1, pp. i92-i97
Closed Access
Julia U. Holle, Augusto Vaglio
Lara D. Veeken (2025) Vol. 64, Iss. Supplement_1, pp. i92-i97
Closed Access
Comparative Insights on IL-5 Targeting with Mepolizumab and Benralizumab: Enhancing EGPA Treatment Strategies
Mayu Shiomi, Ryu Watanabe, Ryuhei Ishihara, et al.
Biomolecules (2025) Vol. 15, Iss. 4, pp. 544-544
Open Access
Mayu Shiomi, Ryu Watanabe, Ryuhei Ishihara, et al.
Biomolecules (2025) Vol. 15, Iss. 4, pp. 544-544
Open Access
EGPA: Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) as a special presentation of chronic rhinosinusitis with nasal polyps (CRSwNP)
Jan Hagemann, Martin Laudien, Sven Becker, et al.
Allergologie select (2024) Vol. 8, Iss. 1, pp. 18-25
Open Access | Times Cited: 2
Jan Hagemann, Martin Laudien, Sven Becker, et al.
Allergologie select (2024) Vol. 8, Iss. 1, pp. 18-25
Open Access | Times Cited: 2
Real-World Safety Profile of Biologic Drugs for Severe Uncontrolled Asthma: A Descriptive Analysis from the Spanish Pharmacovigilance Database
Carlos Boada-Fernández-del-Campo, Marcelino García-Sánchez-Colomer, Eduardo Fernández-Quintana, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 4192-4192
Open Access | Times Cited: 2
Carlos Boada-Fernández-del-Campo, Marcelino García-Sánchez-Colomer, Eduardo Fernández-Quintana, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 4192-4192
Open Access | Times Cited: 2
Long-term efficacy of mepolizumab in patients with eosinophilic granulomatosis with polyangiitis: a propensity score matching analysis in the multicenter REVEAL cohort study
Mayu Shiomi, Ryu Watanabe, Shogo Matsuda, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Mayu Shiomi, Ryu Watanabe, Shogo Matsuda, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Treatment strategies for ANCA-associated vasculitides: from standard protocols to future horizons
Francesco Reggiani, Matteo Stella, Marta Calatroni, et al.
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 7, pp. 765-780
Closed Access | Times Cited: 1
Francesco Reggiani, Matteo Stella, Marta Calatroni, et al.
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 7, pp. 765-780
Closed Access | Times Cited: 1
Benralizumab Reduces Respiratory Exacerbations and Oral Glucocorticosteroid Dose in Patients with Severe Asthma and Eosinophilic Granulomatosis with Polyangiitis
Carlo Mümmler, Pontus Mertsch, Michaela Barnikel, et al.
Journal of Asthma and Allergy (2024) Vol. Volume 17, pp. 557-572
Open Access | Times Cited: 1
Carlo Mümmler, Pontus Mertsch, Michaela Barnikel, et al.
Journal of Asthma and Allergy (2024) Vol. Volume 17, pp. 557-572
Open Access | Times Cited: 1
Relapsing Eosinophilia in a Severe Allergic Asthma Patient on Biological Therapy
Oana Rădună, Bianca Oprescu, Ștefan Mihăicuță, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 12, pp. 3402-3402
Open Access | Times Cited: 1
Oana Rădună, Bianca Oprescu, Ștefan Mihăicuță, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 12, pp. 3402-3402
Open Access | Times Cited: 1
Unmasking eosinophilic granulomatosis with polyangiitis (EGPA)
Luca Moroni, Gabriele Gallina, Lorenzo Dagna
European Journal of Internal Medicine (2024) Vol. 128, pp. 34-35
Closed Access
Luca Moroni, Gabriele Gallina, Lorenzo Dagna
European Journal of Internal Medicine (2024) Vol. 128, pp. 34-35
Closed Access
Dupilumab for refractory chronic rhinosinusitis in eosinophilic granulomatosis with polyangiitis
Roberto Padoan, F. Davanzo, Luca Iorio, et al.
Lara D. Veeken (2024)
Closed Access
Roberto Padoan, F. Davanzo, Luca Iorio, et al.
Lara D. Veeken (2024)
Closed Access
